Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Vaccine Production
Antibodies
Pharmaceutical Drug Development
Clinical Pharmacovigilance Studies
Bioavailability and Bioequivalence Studies
Toxicity Testing Laboratories

Evaluate more than 400,000 products >>

Featured Jobs

Research & Medical, Sr Director, Therapy Acceleration Program (TAP)
The Leukemia & Lymphoma Society - White Plains, NY
Director, Engineering
Xagenic - Toronto, Canada

More Jobs >>

Events

Marketing Pharmaceuticals 2011: Workshop for Regulatory Professionals and Promotional Review Teams
February 21-23, 2011 — Washington, DC
Vaccines Business Congress
March 2-4, 2011 — Baltimore, MD
23rd Annual EuroMeeting - Europe's Premier Conference for Professionals Involved in Drug Development
March 28-30, 2011 — Geneva, Switzerland
Drug Delivery Partnerships
January 26-28, 2011 — Miami, FL

More Events >>

Related Tags >> Vaccine swine flu flu vaccine H1N1

Novartis News

Most Popular Novartis Story

Four big vax makers charge ahead with swine flu programs

June 10, 2009 — 11:36am ET | By John Carroll

Vaccine teams for four of the world's largest vaccine manufacturers say they have the seed stock they need to develop a new swine flu vax for use this autumn. But the researchers add that they're... Read more...

Novartis Press Releases

An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
VIDEO from Novartis Available on thenewsmarket.com: Novartis Presents Data about Tasigna in Treatment of Patients with Newly Dia
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen® (Baclofen Injection) for the Treatment of Severe Spas
Diabetes Product Launch: Prepping the Market Through Thought Leader Outreach
iBio Presents At FDA’s Biosimilars Public Hearing

Latest Headlines

Vax panel votes to add meningitis booster dose
October 27, 2010
Study: Cell culture-derived flu vax appears as effective as egg‐derived one
October 21, 2010
Novartis and Venter team on faster vaccine development
October 7, 2010
HHS chief promises cell-based flu vax in 2011
September 30, 2010
Novartis' meningitis B vax passes test
September 16, 2010
Expect lower flu vax demand in Europe next year
June 30, 2010
New Novartis vaccine guards mice against E. coli
May 6, 2010
Burst of H1N1 vax orders fuel spike in Novartis profits
April 21, 2010
Vaccine makers settle France's H1N1 bill
March 25, 2010
EC approves Novartis' Menveo conjugate vax
March 18, 2010
Novartis VC arm backs fledgling universal flu vax
February 17, 2010
Novartis vax division booms as demand spikes
December 2, 2009
Big Pharma maps out a global vaccine strategy
November 5, 2009
Novartis hails single-dose H1N1 vaccine success
September 3, 2009
Novartis races into the clinic with H1N1 vax
August 6, 2009
Swine flu news roundup
August 5, 2009
Novartis readies trial as H1N1 orders pour in
July 16, 2009
Novartis delayed on Menveo app
July 2, 2009
Panel recommends Intercell's new Japanese encephalitis jab
June 25, 2009
Novartis to help educate a new generation of researchers
June 11, 2009

Paid Research Reports

Russia Pharmaceutical Market Overview - Pharma companies target Russia despite the challenges it presents
Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative) - Triple-negative breast cancer offers a significant opportunity
Infectious Diseases Vaccine Market Overview
Commercial Insight: Top 20 Cancer Therapy Brands
Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issue
The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses

More Research Reports >>

Check out more News by topic

THE FIERCEMARKETS NETWORK